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Vulvodynia is a prevalent chronic pain disorder associated with high medical costs and 
often ineffective treatments. The major pathological feature is proliferation of vaginal 
nerve fibres. This study aimed to develop a highly reproducible animal model to study 
neuroproliferation in the vagina and aid the identification of appropriately targeted 
treatments for conditions such as vulvodynia. Mild chronic inflammation was induced 
using microinjection of complete Freund’s adjuvant in the distal vagina of C57Bl/6 mice. 
Control mice received saline. Inflammation and innervation density were assessed at 7 
and 28 days after a single administration or 14 days following repeated administration of 
complete Freund’s adjuvant or saline. Histochemistry and blinded-analysis of images 
was used to assess vaginal morphology (H & E) and abundance of macrophages 
(CD68-labelling), mast cells (toluidine blue staining, mast cell tryptase-immunoreactivity), 
blood vessels (αSMA-immunoreactivity) and nerve fibres immunoreactive for the pan-
neuronal marker PGP9.5. Subpopulations of nerve fibres were identified using 
immunoreactivity for calcitonin gene-related peptide (CGRP), substance P (SP), 
vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY). Single administration of 
complete Freund’s adjuvant resulted in vaginal swelling, macrophage infiltration, 
vascular proliferation and increased abundance of nerve fibres immunoreactive for 
CGRP, SP, VIP and/or PGP9.5 but not NPY, evident at seven days. Inflammation further 
increased following repeated administration of complete Freund’s adjuvant but nerve 
fibre proliferation did not. Nerve fibre proliferation continued to be evident at 28 days. 
The inter-individual differences within each treatment group were small, indicating this 
model may be useful to study mechanisms underlying vaginal nerve fibre proliferation 




Vulvodynia is a prevalent chronic pain disorder of the distal female reproductive tract 
with unclear aetiology (Pukall et al., 2016). Clinical signs include evidence of nociceptor 
sensitisation (Bohm-Starke et al., 2001) and pathological features include increased 
numbers of vaginal nerve fibres (Bohm-Starke et al., 1998, Tympanidis et al., 2003, 
Goetsch et al., 2010, Liao et al., 2017), possibly resulting from inflammation (Akopians 
and Rapkin, 2015, Liao et al., 2017). Treatments for vulvodynia include topical and 
systemic medications, physical therapy, sexual counseling and surgery, but these are 
often ineffective (Harlow et al., 2014). Direct medical costs are high, exceeding $21 
billion annually in the United States (Xie et al., 2012). Current understanding of the 
processes underlying neuroproliferation in response to vaginal inflammation is limited.  
 
Vaginal innervation includes projections of sympathetic, parasympathetic and sensory 
neurons. Many nerve fibres in the vagina contain peptides such as vasoactive intestinal 
polypeptide (VIP), calcitonin gene-related peptide (CGRP), substance P (SP) and 
neuropeptide tyrosine (NPY) that regulate blood flow and nociception (Huang et al., 
1984, Hoyle et al., 1996). The types of nerve fibres contributing to hyperinnervation in 
vulvodynia are largely unknown. 
 
Hyperinnervation of synovium and skin has been shown in mouse models of joint and 
hind paw inflammation, induced using complete Freund’s adjuvant (CFA) (Ghilardi et al., 
2012, Chakrabarty et al., 2013). CFA is comprised of heat-inactivated mycobacterium 
emulsified in mineral oil and the gradual release of antigens from the suspension 
produces a sustained immune response, making CFA useful in models of chronic 
inflammation (Billiau and Matthys, 2001) (Su et al., 2005). To our knowledge CFA has 
not previously been used in studies of the female genital tract and the impact of mild 
chronic inflammation on the innervation pattern of peptidergic nerve fibres in the vagina 
is unclear.  
 
Therefore this study aimed to investigate the impact of mild chronic inflammation 
induced by CFA on innervation of the murine vagina. We focused on nerve fibres 






All experiments were performed according to the guidelines established by the National 
Health and Medical Research Council of Australia and were approved by the Animal 
Welfare Committee of Flinders University. 
 
Induction of inflammation 
Under general anaesthesia with isoflurane (induction 4%, maintenance 1.5%) in oxygen, 
female mice (C57Bl/6 6 to 8 weeks of age, independent of the oestrus cycle) received 
injection of CFA (Sigma-Aldrich, Missouri, USA) into the wall of the distal vagina. Control 
mice were injected with 0.9 % saline using the same procedures. To optimize the 
injection procedure, pilot studies (n = 3 mice) were undertaken in which 5 µl of Evan’s 
blue dye (5% in 0.9% saline) was injected into the distal vaginal wall and dissection 
performed immediately afterwards to confirm the distribution of dye. To minimize trauma 
to the mucosa, injection was administered using a glass micropipette (inner diameter: 
1.5 mm; World Precision Instruments, FL, USA), which had been pulled on a Flaming 
Brown micropipette puller (Sutter Instrument Co. CA, USA) to produce a tip diameter of 
approximately 5 µm and a custom-made pressure injection system (Biomedical 
Engineering, Flinders University) was used to inject 5 µl of solution. To visualize the 
distribution of injected substances during the procedure, a small quantity of Evan’s blue 
dye (5%) was included in injected solutions. Following injection, anaesthesia was 
withdrawn and mice recovered. Following the procedure all mice were monitored at least 
twice daily for any evidence of pain or distress, including weight loss, exploratory 
behaviour deficits, licking or biting response to urogenital tract inflammation, piloerection 
and facial grimace scale (Langford et al., 2010). After 7 days mice were either 
euthanized by isoflurane overdose and heart removal (CFA 7d n = 7, Saline 7d n = 4), or 
anaesthetized again and administered a second time with CFA or saline using the same 
procedures described previously. These mice were then allowed to recover for a further 
7 days with monitoring as previously described and then euthanized by isoflurane 
overdose and heart removal (CFA 14d n = 6, Saline 14d n = 4). An additional group of 
mice were euthanized at 28 days following a single administration of CFA (CFA 28d, n = 




Tissue preparation and sectioning 
Tissue sections were used to assess the presence of inflammation and to semi-
quantitate nerve fibres distributed in different layers of the murine vagina in proximal 
(cervical) and distal (vulvar) segments. Following euthanasia, the vagina together with 
the urethra was dissected and proximal and distal segments isolated (Fig. 1A). Tissue 
was fixed overnight at 4°C in Zamboni’s fixative (2% formaldehyde; 0.5% picric acid; 
0.2M sodium phosphate buffer, pH 7.0), then dehydrated in ethanol (80% 3 x 20 min, 
90% 1 x 30 min, 100% 2 x 30 min), cleared in xylene (2 x 30 minutes) and rehydrated 
through a series of ethanol washes (100% 2 x 30 min, 80% 1 x 30 min, 50% 1 x 30 min) 
to water (1 x 30 min). Tissue was transferred into 30% sucrose in PBS overnight at 4°C 
then shock frozen in OCT compound (Tissue-Tek, Miles, USA). Cryostat sections were 
cut at 12 µm thickness, mounted on polyethyleneimine-coated slides and vacuum dried 
for 30 minutes. For each histological stain and each combination of antibodies, five 
sections from the proximal and five sections from the distal segment of the vagina per 
mouse were labelled, with at least 100 µm distance between sections labelled with the 
same stain or antibody combination. 
 
Histochemistry 
Haematoxylin and eosin (H&E) staining was used to visualise vaginal tissue morphology 
following microinjection of CFA or saline. Sections were washed in PBS and stained 
according to standard protocols (haematoxylin 45 s, 1% acid alcohol 5 s, lithium 
carbonate 1 min, eosin 5 – 7 s, 100% ethanol 3 x 10 s and xylene 2 x 1 min). Sections 
were washed under running water (1 min) after immersion in each reagent before 
dehydration in ethanol. Slides were coverslipped using DePex mounting medium (BDH 
Chemicals, Poole, UK).  
 
Toluidine blue staining was performed to identify mast cells in the vagina following 
microinjection of CFA or saline. Slides were washed in PBS to remove OCT, 
subsequently toluidine blue working solution (1%) was applied for 5 min, sections 
washed again in PBS then coverslipped in carbonate-buffered glycerol at pH 8.6. 
Multiple labelling immunohistochemistry was used to identify specific populations of 
nerve fibres, CD68 immunoreactive cells, mast cells and blood vessels containing alpha-
smooth muscle actin (αSMA). Non-specific binding was blocked using 10% normal 
donkey serum in PBS (30 minutes), and sections were incubated in primary antisera 
  
(Appendix, Table A.1) for 48 hours in a humid chamber at room temperature. 
Combinations of primary antisera are also listed in the appendix table. The pan-neuronal 
marker protein gene product 9.5 (PGP9.5) was used to identify all nerve fibres, and 
subpopulations of fibres were identified by immunoreactivity for SP, CGRP and VIP. 
Alpha-smooth muscle actin was used to identify blood vessels. The 
monocyte/macrophage marker CD68 was used to assess the presence of macrophages 
and histamine was used as a marker of mast cells. After exposure to primary antisera, 
sections were washed in PBS (3 x 10 min), incubated in combinations of secondary 
antisera (Table A.1) for 2 hours at room temperature, washed in PBS (3 x 10 min) and 
coverslipped in carbonate-buffered glycerol at pH 8.6.  
 
Antibody characterisation 
Primary antibodies and antisera used in this study are summarised in the Appendix 
(Table A.1). The monoclonal αSMA antibody, produced using a mouse-derived 
hybridoma (Skalli et al., 1986) labels a 42-43 kD band on Western blot (Yang et al., 
2001, Lennerz et al., 2008). The polyclonal CGRP antibody has been extensively 
characterized in previous studies (Morris et al., 2005b, Clarke et al., 2011, Vilimas et al., 
2011, Yuan et al., 2011), shows no cross-reactivity with unrelated peptides in sensory or 
autonomic ganglia (Gibbins and Matthew, 1996) and exhibits labelling consistent with 
other reported CGRP antibodies (Gibson et al., 1984, Franco-Cereceda et al., 1987). 
The polyclonal PGP9.5 antibody (Doran et al., 1983) labels a band at 26 – 28 kD on 
Western blot (Krimm et al., 2006, Van Acker et al., 2016), and labels neurons and nerve 
fibres of peripheral and central nervous system and some neuroendocrine cells (Wilson 
et al., 1988). The monoclonal SP antibody (Millipore), produced using a hybridoma 
(Cuello et al., 1979) has shown specificity in radioimmunoassay using recombinant 
substance P or tissue extracts (Cuello et al., 1979). This antibody strongly labels the 
substantia gelatinosa of the spinal cord (Cuello et al., 1979) and a subset of peripheral 
nerve terminals in skin and viscera of mice and guinea pigs (Morris et al., 2005a). We 
have previously shown specificity of the polyclonal VIP antibody using pre-adsorption 
studies (Morris et al., 1985). No labelling was seen when preparations were treated only 





Microscopy and image analysis 
Sections stained for haematoxylin and eosin (H&E) were viewed using brightfield 
microscopy (Olympus BX50) and images acquired using a 4 x objective lens. To assess 
the impact of oedema associated with inflammation on the dimensions of the vaginal 
wall, the cross-sectional area of the lamina propria was measured using the freehand 
selection tool and measure function in ImageJ. Sections stained for toluidine blue were 
viewed with brightfield microscopy using a 20 x objective lens and the number of mast 
cells per 200,000 µm2 field was counted in each section. 
 
Immuno-labelled sections were imaged using an epifluorescence microscope (Olympus 
BX50, Tokyo, Japan) with selective excitation LED (CoolLED Ltd, Hampshire, UK) and 
emission filter combinations. Images were acquired using a CoolSNAP fx 
monochromatic camera (Photometrics, Az, USA) and MicroManager Imaging Software 
(UCSF, Ca, USA). CD68-immunolabelled cells in 6 regions of interest per mouse were 
imaged using a 20 x objective lens. Images were imported to ImageJ (NIH, Bethesda, 
MD, USA) and a 9 x 7 point grid was overlaid using the digital Grid tool. CD68-
immunoreactive cells intersecting with points on the grid were manually counted, by a 
researcher blinded to the treatment group, according to techniques previously validated 
(Gibbins et al., 2003, Gibbons et al., 2010). To compare the number of blood vessels 
showing immunoreactivity for αSMA in each group, 3 regions per section (30 regions of 
interest per mouse) were imaged using a 10 x objective lens. The number of αSMA-
immunoreactive blood vessels per field was counted for n = 6 mice per group that 
received injections of CFA and n = 3 mice per group that received injections of saline. 
To compare the number of immunoreactive nerve fibres in each group, images were 
acquired from three regions per section (Fig. 1B) using a 20 x objective lens. Thirty 
regions of interest per mouse were imaged for naiive, CFA 7d, Saline 7d, CFA 14d and 
Saline 14d groups. Eighteen regions of interest per mouse were imaged for CFA 28d 
and Saline 28d groups. Images were imported to ImageJ (NIH, Bethesda, MD, USA) 
and a 9 x 7 point grid was overlaid using the digital Grid tool. Immunoreactive nerve 
fibres intersecting with points on the grid were manually counted by researchers blinded 
to the treatment group. 
 
High-resolution images of immunolabelled sections were acquired using a confocal laser 
scanning microscope (TCS SP5, Leica, Bensheim, Germany) with Leica Application 
  
Suite Advanced Fluorescence software (Leica Microsystems, Wetzlar, Germany) and 
oil-immersion objective lenses. Images were prepared for publication using Adobe 
Photoshop (V14.2) and Adobe Illustrator (V17.1).  
 
Statistical analysis 
For parametric tests, normal distributions and the equality of group variances were 
assessed using Shapiro-Wilk tests and Levene’s test in SPSS (V23 Armonk, NY, IBM 
Corp.), and no deviations from normality or differences in variance were shown. Data 
were analysed in GraphPad Prism (Graphpad Software V6, San Diego), using analysis 
of variance (ANOVA) followed by Bonferroni post-tests, and are displayed as mean ± 
standard error of the mean. The relationship between outcome measures was assessed 






Pilot studies showed injected solutions spread throughout the distal vagina and 
dispersed towards the proximal vagina (data not shown). There was no leakage into 
adjacent viscera or into the peritoneal space. No physical damage was apparent when 
fine micropipette tips were impaled into or retracted from the vagina in vivo, as observed 
using a surgical/dissection microscope. Following injection of CFA or saline, the mice 
showed no evidence of pain or distress throughout the monitoring period, except a small 
proportion (< 10%) that demonstrated licking of the urogenital region for 5 to 10 seconds 
only during recovery from anaesthesia following injection of CFA. Mice injected with CFA 
showed lamina propria thickening, increased presence of CD68-immunoreactive cells, 
increased abundance of blood vessels and increased nerve fibre density, including 
increased numbers of nerve fibres immunoreactive for CGRP, SP and VIP.  
 
Morphological evidence of oedema 
CFA produced swelling of the vagina, shown by increased cross sectional area (Fig. 1 C, 
D). Lamina propria area was significantly increased at 7 days following a single CFA 
administration (F1, 6 = 34.8, p < 0.01) and at 14 days, following repeated CFA 
administration (F1, 6 = 504.0, p < 0.001, Fig. 2A), compared to mice that received saline. 
Swelling was greater in mice that received two administrations of CFA (CFA 14d group) 
compared to mice that received a single administration (CFA 7d group, F1, 8 = 151.5, p < 
0.0001), and was greater in the distal compared to the proximal vagina (CFA 7d vs 
Saline 7d, F1, 6 = 145.0, p < 0.0001; CFA 14d vs Saline 14d, F1, 6 = 402.1, p < 0.0001). In 
control groups of mice, lamina propria area was the same in proximal and distal 
segments of the vagina. At 28 days following CFA, swelling in the distal vagina was no 
longer evident (Fig. 2A). 
 
Immune cell infiltration 
Vaginal tissue contained an increased number of CD68-immunoreactive cells following a 
single administration of CFA compared to saline (F1, 7 = 312.7, p < 0.0001, Fig. 2B). 
Repeated administration of CFA produced a further increase in CD68-immunoreactive 
cells (F1, 5 = 2302, p < 0.0001), where as in control mice, the number of CD68-
immunoreactive cells was the same in 7d and 14d groups. Mice that received CFA had 
more abundant CD68-immunoreactive cells in the distal vagina compared to the 
  
proximal vagina (CFA 7d, F1, 7 = 100.7, p < 0.0001; CFA 14d, F1, 5 = 162.4, p < 0.0001) 
whereas control mice had the same number of CD68-immunoreactive cells in the 
proximal and distal vagina. In contrast to changes involving the number of CD68-
immunoreactive cells in the vagina, mast cells visualized by toluidine blue staining or by 
immunoreactivity to histamine were equally abundant in mice that received CFA or 
saline with only 1 to 2 mast cells per 200,000 µm2 field identified in all groups of mice. 
 
Vascular proliferation 
More blood vessels identified by αSMA-immunoreactivity of the tunica media were 
identified in mice that received a single (F1, 7 = 22.5, p < 0.01) or repeated administration 
of CFA (F1, 7 = 37.1, p < 0.001) compared to mice that received saline (Fig. 2C). 
Compared to CFA 7d mice, CFA 14d mice showed no further increase in blood vessel 
numbers identified by αSMA. Whereas mice that received saline showed the same 
number of αSMA-immunoreactive blood vessels in the distal and proximal vagina, mice 
that received CFA tended to have more vessels identified by αSMA in the distal vagina. 
 
Innervation density 
In all groups of mice, independent of treatment, innervation density was greater in the 
proximal compared to the distal vagina (F1, 11 = 33.9, p = 0.0001, Fig. 2D). Saline 
administration caused no change in innervation density compared to naïve mice, 
whereas innervation increased in mice that received CFA (Fig. 2D, 3). Seven days 
following a single administration of CFA, the number PGP9.5-immunoreactive nerve 
fibres per field was higher in proximal and distal segments compared to naiive and 
saline control mice (F2, 11 = 57.2, p < 0.0001). CFA 14d mice showed increased 
innervation in the proximal vagina compared to Saline 14d mice and naiive mice (F2, 11 = 
11.6, p = 0.002, Fig. 2D). Compared to a single administration of CFA (CFA 7d group), 
no further increase in innervation density was identified following repeated 
administration (CFA 14d group). CFA 28d mice showed increased innervation compared 
to naiive mice (F1, 6 = 8.7, p = 0.03, Fig. 2D), with increased innervation density in 
proximal and distal segments of the vagina similar to other mice treated with CFA. 
Innervation density in the distal vagina of CFA 14d mice could not be reliably assessed 
due to substantial oedema and many fields containing sparse tissue and few identifiable 
nerve fibres. Comparing the impact of CFA on the number of PGP9.5-immunoreactive 
nerve fibres in proximal and distal segments of the vagina in CFA 7d mice, a more 
  
pronounced response appears in the distal segment. Innervation density in the proximal 
vagina increased by 44% in mice that received CFA compared to saline (Saline 7d: 
mean total 40 ± 1 fibres per segment, n = 4; CFA 7d: 57 ± 3, n = 6) whereas in the distal 
vagina, innervation density increased by over 50% in mice that received CFA compared 
to saline (Saline 7d: 30 ± 2, n = 4; CFA 7d: 46 ± 2, n = 6). Neither CFA 7d mice nor CFA 
14d mice showed any correlation between segmental innervation density and the 
number of CD68 cells, the number of αSMA-blood vessels or the cross-sectional area of 
the lamina propria. 
 
Neurochemical characteristics of nerve fibres 
In all mice, nerve fibres immunoreactive for CGRP, SP or VIP were most abundant in 
the lamina propria layer of the vagina whereas nerve fibres immunoreactive for NPY 
were mainly restricted to the adventitia and muscularis. Compared to saline controls, 
vaginal sections from CFA 7d mice contained significantly more nerve fibres 
immunoreactive for CGRP (F1, 16 = 29.2, p < 0.0001, Fig. 4A), SP (F1, 16 = 15.6, p < 0.01, 
Fig. 4B) and VIP (F1, 16 = 10.1, p < 0.01, Fig. 4C). Repeated administration of CFA 
produced no further increase in nerve fibres immunoreactive for any of these peptides. 
Comparing proximal and distal segments, the proximal vagina showed a greater 
increase in innervation by nerve fibres immunoreactive for CGRP (F1, 16 = 6.3, p < 0.05, 
Fig. 4D). Post-tests showed that in the proximal vagina, innervation by nerve fibres 
immunoreactive for SP and VIP was also increased (Fig. 4E, F). We did not identify 
proliferation of nerve fibres containing NPY and in mice that received CFA. NPY-
immunoreactive fibres remained mostly restricted to the outer layers of the vagina. 
 
For all mice there was a positive correlation between the number of nerve fibres 
immunoreactive for PGP9.5 and for CGRP (r = 0.95, p < 0.0001). In contrast, there was 
no correlation between the number of fibres of any specific immunoreactivity assessed 
and the number of CD68 cells, the number of blood vessels identified by αSMA or the 





This study shows that microinjection of CFA induces inflammation and hyperinnervation 
in the mouse vagina. A single administration of CFA produced oedema, influx of 
macrophages and proliferation of blood vessels and nerve fibres, all evident after 7 days. 
Repeated administration of CFA produced greater oedema, macrophage influx and 
abundance of blood vessels, but no change in the density of nerve fibres. The increased 
number of nerve fibres was not restricted to one population but involved multiple, 
neurochemically distinct types of neurons. The nerve fibre proliferation was not coupled 
to overt pain behaviour since throughout the study, mice showed no signs of pain or 
distress, consistent with mild chronic inflammation as opposed to severe acute 
inflammation. 
 
The increase in the area of the lamina propria following CFA administration is consistent 
with vaginal swelling due to vasocongestion and oedema, increased water content in 
tissues. Not surprisingly, swelling was more prominent in the distal vagina, closer to the 
site of CFA administration, and CFA 7d mice showed swelling in the distal vagina only. 
Greater swelling followed repeated administration of CFA, and CFA14d mice showed 
swelling of both segments. For this group, lamina propria area in the distal vagina 
increased over 2.5 fold compared to sham mice, whilst a more modest increase, less 
than 20%, was seen in the proximal vagina. Despite the substantial oedema produced in 
response to CFA, animal-to-animal variation within each group was surprisingly small. 
This points towards an advantageous model. Studies in CFA-induced inflammation in 
other tissues also reported a robust inflammatory response to CFA with marginal animal-
to-animal variation, e.g. 50% increase in mouse hind paw volume at 24 hours, 
maintained at 7 days following intra-plantar injection of CFA (20 µl), (Cobos et al., 2012). 
 
Infiltration of immune-competent cells is a hallmark of inflammation and cells labelled for 
CD68 were more numerous in vaginal tissue of mice that received CFA. CD68 is a 
transmembrane glycoprotein expressed by cells of monocyte lineage (Holness and 
Simmons, 1993). It is most commonly used as a marker for macrophages, which play 
key roles in inflammation production and resolution (Fujiwara and Kobayashi, 2005). 
CD68-immunoreactive cell counts were higher following repeated administration of CFA 
compared to a single administration, and cell counts were higher in the distal compared 
to the proximal vagina. Not surprisingly, vaginal tissue that received the highest 
  
exposure to the pro-inflammatory stimulus contained the highest number of CD68-
immunolabelled cells. CD68 cell infiltration appears to be a relatively sensitive measure 
of inflammation; no oedema was identified in the proximal vagina of CFA 7d mice yet 
this region contained 80% more CD68-labelled cells compared to controls. Our results 
are consistent with previous studies that have identified macrophage infiltration in CFA 
models of hind paw inflammation (Jha et al., 2014) and joint inflammation (Ghilardi et al., 
2012). The results in our model corroborate patient studies that identified increased 
numbers of CD68-labelled cells in vestibular biopsies of women with vestibulodynia, a 
localized form of vulvodynia involving pain associated with the vaginal vestibule (Liao et 
al., 2017). Thus, infiltration of CD68-positive cells is present in human pathology and in 
this proposed animal model. 
 
Mast cells are also often associated with inflammation but, in contrast to increased 
putative macrophages in vaginal tissue following administration of CFA, there was no 
increase in mast cells. This was confirmed by two methods to identify mast cells, which 
yielded equivalent results. Resident mast cells are part of the innate immune system and 
release mediators that contribute to nociceptor sensitisation (Drummond, 2004, Ren and 
Dubner, 2010). Mast cell accumulation in vulvar tissue has been described in a mouse 
model of oxazolone induced hypersensitivity, concurrent with hyperinnervation involving 
CGRP-immunoreactive nerve fibres (Landry et al., 2017). The results of clinical studies 
are variable. In women with provoked vestibulodynia, pathology regarding increased 
presence of mast cells is variable (Chalmers et al., 2016). Mediators released by mast 
cells can contribute to sensitisation and proliferation of peripheral nociceptors and a 
potential limitation of our model relates to its utility for studies into mechanisms involving 
mast cells that may contribute to vulvodynia. Whilst the significance of mast cells in 
vaginal hyperinnervation and nociceptor sensitization in vulvodynia remains unclear, our 
model provides evidence that hyperinnervation can occur independent of changes in 
mast cell numbers. Recent studies using a rat model of CFA-induced vulvodynia indicate 
an important role for macrophages and T cells, via increased renin and angiotensinogen 
leading to promotion of axonal sprouting through AT2 receptor activation (Chakrabarty et 
al., 2017). 
 
Substantial vascular proliferation was observed in vaginal tissue of mice that received 
CFA. After a single administration, a 2-fold increase in αSMA-labelled blood vessels was 
  
identified in the distal vagina. After repeated administration of CFA, the number of blood 
vessels further increased in both segments of the vagina. Consistent with findings 
regarding swelling and macrophage infiltration, vascular proliferation was greater in the 
distal vagina, but was also substantial in the proximal vagina which contained more than 
double the number of αSMA-vessels after repeated CFA administration. As αSMA-
labelling selectively identifies arterioles and other vessels containing smooth muscle, the 
2- to 3-fold increase in the number of vessels identified is a conservative measure of 
total vascular proliferation as capillaries which do not show αSMA-immunoreactivity are 
more abundant. Angiogenesis is a key response to tissue insult and vessel proliferation 
is rapid (DiPietro, 2016). Endothelial cell proliferation in tracheal microvasculature has 
been shown within 24 hours of inoculation with Mycoplasma pulmonis, peaking at 5 days, 
though remaining elevated for 28 days compared to control mice (Ezaki et al., 2001). 
Our data is also consistent with experimental studies showing CFA-induced endothelial 
cell proliferation in mouse synovium (Ghilardi et al., 2012). Furthermore, clinical studies 
show patients with rheumatoid arthritis have increased vessels labelling for αSMA, and 
the increase correlates with ultrasound measures of joint disease severity (Kelly et al., 
2015). An interesting question is whether hyperinnervation associated with vulvodynia 
mainly involves perivascular nerve fibres. It has been shown that many nociceptive 
afferents in health tissues are perivascular (Gibbins et al., 1985). Interestingly, our 
search of the literature found no reports of vascular proliferation in vaginal biopsies from 
women with vulvodynia, and one study reported vascular proliferation was not evident in 
haematoxylin and eosin labelled samples from women with vestibulitis (Halperin et al., 
2005). The presence and potential significance of angiogenesis in vulvodynia requires 
clarification. 
 
Hyperinnervation in vaginal biopsies is the major pathological feature associated with 
vulvodynia (Bohm-Starke et al., 1998, Tympanidis et al., 2003, Halperin et al., 2005, 
Leclair et al., 2011, Liao et al., 2017). In our model, a single administration of CFA 
produced substantial hyperinnervation involving both segments and therefore the entire 
length of the mouse vagina. Surprisingly, no further increase in innervation was 
identified following a second administration of CFA. However, it should be noted that the 
accuracy of innervation density measurement in CFA 14d mice could have been limited 
by the substantial oedema in this group. An association between hyperinnervation and 
increased mechanical sensitivity has been demonstrated in the repeated fungal infection 
  
model of vulvodynia, in which mice with vaginal hyperinnervation demonstrate 
mechanical allodynia (Farmer et al., 2011). In the fungal infection model of vulvodynia, 
mechanical allodynia was demonstrated to persist after resolution of acute inflammation. 
In contrast to the fungal infection model, the present study describes a model of vaginal 
hyperinnervation, not vulvodynia, as altered pain sensitivity cannot be inferred. The 
consistent hyperinnervation response to CFA and limited animal-to-animal variation 
identified in the present study is similar to the consistent hyperinnervation response 
identified in CFA models of hind paw and joint inflammation (Ghilardi et al., 2012, 
Chakrabarty et al., 2013). This supports the view that CFA administration can provide a 
robust model to study vaginal hyperinnervation. Any studies utilizing this model must 
recognise that dispersion of CFA can result in inflammation and hyperinnervation not 
confined to the injection site. 
 
Using multiple labelling we investigated if hyperinnervation was restricted to specific 
nerve fibre populations. We found multiple populations of fibres contributed to 
hyperinnervation in response to CFA. CGRP-immunoreactive, SP-immunoreactive and 
VIP-immunoreactive nerve fibres were all more abundant, as were nerve fibres identified 
by PGP9.5 and not labelling for any peptide investigated. In contrast, proliferation of 
nerve fibres containing the peptide NPY was not evident following administration of CFA.  
Our finding regarding proliferation of CGRP-containing nerve fibres is consistent with 
that shown in the oxazolone hypersensitivity model of vulvodynia (Landry et al., 2017), 
and proliferation of CGRP-containing nerve fibres identified in a subset of mice (40%) 
that demonstrated hyperalgesia in the repeated fungal infection model of vulvodynia, 
following three rounds of candida albicans infection (Farmer et al., 2011). Further work is 
required to precisely identify the origin of nerve fibres, however it has been shown that 
CGRP- and SP- containing nerve fibres in the mouse vagina are associated with lumbar 
and sacral DRG, and these peptides are not found in autonomic ganglion neurons 
associated with the vagina (Jobling and Lim, 2008, Vilimas et al., 2011, Barry et al., 
2017). 
 
In addition to proliferation of CGRP- and SP-containing nerve fibres, proliferation of VIP-
containing fibres was identified following administration of CFA. Proliferation of VIP-
containing nerve fibres has previously been shown in a rat model of colitis (Miampamba 
and Sharkey, 1998) and further investigation is warranted to identify the role and origin 
  
of these fibres. VIP is a potent vasodilator, known to increase vaginal blood flow and 
lubrication (Ottesen et al., 1987). Anti-inflammatory effects of VIP have been shown in 
animal models and in vitro studies (Chedid et al., 2017). The mouse vagina contains 
multiple populations of VIP-immunoreactive nerve fibres, including projections of 
sensory and autonomic neurons (Costa et al., 1988, Barry et al., 2017). Further studies 
are required to determine if VIP-containing postganglionic projections of pelvic ganglion 
neurons contribute to vaginal hyperinnervation. 
 
An important question is does vaginal hyperinnervation in this model reflect 
hyperinnervation seen in patients? Neurochemical characterization of nerve fibres in 
vaginal biopsies from women with vulvodynia is limited. Increased CGRP-containing 
nerve fibres (Bohm-Starke et al., 1999) and fibres expressing TRPV1 (Tympanidis et al., 
2004) and TRPV4 (Liao et al., 2017) have been identified. TRPV1 receptors are 
activated by multiple mechanical and chemical stimuli and are mainly found in 
nociceptors, including many DRG neurons containing both SP and CGRP (Price and 
Flores, 2007). TRPV4 receptors contribute to mechano-nociception and are found in a 
subset of CGRP-immunoreactive nerve fibres (Brierley et al., 2008). Therefore initial 
results indicate increased innervation by CGRP and SP containing fibres in this model 
may reflect aspects of axonal proliferation in women with vulvodynia. 
 
In summary, microinjection of CFA in the distal vagina of mice produced swelling, 
macrophage infiltration, vascular proliferation and vaginal hyperinnervation involving 
multiple types of nerve fibres. Repeated injection of CFA produced greater inflammation 
without increasing innervation. Inflammation was greater in the distal compared to the 
proximal vagina, whereas hyperinnervation was more prominent in proximal vagina, and 
involved CGRP-, SP- and VIP-immunoreactive nerve fibres, in addition to nerve fibres 
not labelling for any of these peptides. The highly reproducible innervation changes in 
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Fig. 1  
Tissue sampling and H & E stained sections 
A) Sections for analysis were taken from proximal (cervical) and distal (vulvar) regions of 
the vagina. Uh, uterine horn; Bl, bladder. B) Using the urethra for orientation, three 
regions of interest per section were imaged for quantification of immunoreactive cells, 
blood vessels and nerve fibres. C, D) Typical H & E stained sections showing general 
morphology of the vaginal wall including larger lamina propria area in this section from a 
CFA 14d mouse (D) compared to a saline control (C). U, urethra; L, vaginal lumen; E, 
epithelium; LP, lamina propria; M/A, muscularis and adventitia. Bar = 500 µm. 
 
Fig. 2 
Inflammation and hyperinnervation following administration of CFA 
A) Mean lamina propria area in sections of the proximal and distal vagina in CFA 7d, 
14d and 28d mice and corresponding control groups. In control mice, lamina propria 
cross-sectional area was the same in the proximal and distal vagina, and the same in 
Saline 14d compared to Saline 7d mice. CFA 7d and CFA14d mice showed increased 
lamina propria area, consistent with swelling. Swelling was maximal in CFA 14d mice in 
the distal vagina, and returned to baseline levels here at 28 days. B) Mean number of 
CD68-labelled cells per 200,000 µm2 field in sections from the proximal and distal 
vagina. In control mice, the number of CD68-labelled cells was similar in sections from 
the proximal and distal vagina, and the same in Saline 14d compared to Saline 7d mice, 
and increased in mice that receive CFA, consistent with macrophage infiltration. C) The 
mean number of blood vessels per 200,000 µm2 field identified by labelling for αSMA in 
CFA 7d mice and 14d mice compared to saline controls. Increases in CFA groups are 
consistent with vascular proliferation and are most pronounced in in the distal vagina 
where αSMA-labelled blood vessels were equally abundant in CFA14d and CFA 7d 
mice. D) The mean number of nerve fibres per 200,000 µm2 field identified by 
immunoreactivity for PGP9.5 in vaginal sections of all groups of mice. Innervation 
density was the same in naiive, Saline 7d and Saline 14d mice. All groups that received 
CFA showed increased innervation density compared to controls and no differences 
were identified between CFA 7d, CFA 14d and 28d mice.  
 
  
Asterisks show where Bonferroni post-tests indicate differences between groups that 
received CFA and Saline (* p < 0.05, ** p < 0.01, **** p < 0.0001). Hashes show where 
Bonferroni post-tests indicate differences between groups that received CFA (# p < 0.05, 
# # # # p < 0.0001). Cross shows when Bonferroni post-tests indicates differences 
between CFA and naiive.  
 
Fig. 3  
Innervation changes following administration of CFA 
Confocal microscopy images (z depth 10 µm) of vaginal sections labeled for αSMA 
(green) and PGP9.5 (red). A – C) Section from the proximal vagina of a Saline 7d 
mouse showing nerve fibres present in all layers of the vagina, particularly abundant in 
the lamina propria. D – F) Section from the proximal vagina a CFA 7d mouse showing 
increased abundance of nerve fibres, particularly in the lamina propria. a, adventitia; m, 
muscularis; lp lamina propria; e epithelium. Bar = 50 µm. 
 
Fig. 4  
Abundance of vaginal nerve fibres immunoreactive for CGRP, SP and VIP 
A – C) Graphs show the mean number of nerve fibres per 200,000 µm2 field in sections 
of the proximal vagina, immunoreactive (+) for a specific peptide. A) Compared to saline 
controls (n = 4 per group), mice that received CFA (n = 6 per group) had more nerve 
fibres immunoreactive for CGRP (ANOVA, p < 0.0001). Abundance of these fibres was 
the same in CFA 14d mice compared to CFA 7d mice. B) Mice that received CFA also 
had increased density of nerve fibres immunoreactive for SP (ANOVA, p < 0.05). C) 
Nerve fibres immunoreactive for VIP were also increased in mice that received CFA 
(ANOVA, p < 0.05). D – F) Graphs show the mean number of nerve fibres per field 
immunoreactive for a specific peptide in proximal and distal segments of the vagina of 
CFA 7d and Saline 7d mice. ANOVA showed increases in the number of nerve fibres 
immunoreactive for CGRP (p < 0.0001), SP (p < 0.01) and VIP (p < 0.01) in mice that 
received CFA compared to controls, and for each of these peptides, increased 
innervation was more prominent in the proximal vagina. Asterisks indicate where 





Antibody Immunogen Host, source, catalogue number
Alpha smooth muscle actin (αSMA)  Synthetic NH2-terminal decapeptide of α-
SMA conjugated to keyhole limpet 
hemocyanin 
Mouse, Sigma-Aldrich, A2547 
 
Calcitonin gene-related peptide (CGRP) Rat CGRP conjugated to gamma globulin Goat, Arnel, USA, 1780
Neuropeptide tyrosine (NPY) Synthetic NPY conjugated to bovine 
thyroglobulin type II using carbodiimide. 
Sheep, Dr Oliver and Dr Blessing
Australia, E2210 
Protein gene product 9.5 (PGP9.5) Human PGP9.5 purified from human brain Rabbit, Ultraclone, UK
 
Substance P (SP) SP conjugated to bovine serum albumin Rat, Millipore, Millipore, MAB356
 
Vasoactive intestinal polypeptide (VIP) Porcine VIP conjugated to thyroglobulin Rat, Dr Murphy, Australia, F/III
 




FITC anti-mouse IgG 
CY3 anti-rabbit IgG 




Biotin anti-rabbit IgG + DTAF-SA 
CY3 anti-rat IgG 




Biotin anti-rabbit IgG + DTAF-SA 
CY3 anti-rat IgG 
CY5 anti-sheep IgG 
 








• Complete Freund’s adjuvant was microinjected into the distal vagina of C57Bl/6 mice  
 
• Vaginal swelling and increased macrophages and blood vessels were evident at 7 days 
and 14 days 
  
• Hyperinnervation was evident at 7, 14 and 28 days and involved multiple types of nerve 
fibres 
 
• Proximal and distal regions of the vagina contained inflammation and hyperinnervation 
 
• Repeated administration of adjuvant increased inflammation but not hyperinnervation 
 
 
 
